- Home
- TSVT vs JCE Comparison
TSVT vs JCE Comparison
Compare TSVT & JCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- JCE
- Stock Information
- Founded
- TSVT 2021
- JCE 2007
- Country
- TSVT United States
- JCE United States
- Employees
- TSVT N/A
- JCE N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- JCE Trusts Except Educational Religious and Charitable
- Sector
- TSVT Health Care
- JCE Finance
- Exchange
- TSVT Nasdaq
- JCE Nasdaq
- Market Cap
- TSVT 253.9M
- JCE 244.6M
- IPO Year
- TSVT N/A
- JCE N/A
- Fundamental
- Price
- TSVT $4.82
- JCE $15.29
- Analyst Decision
- TSVT Buy
- JCE
- Analyst Count
- TSVT 6
- JCE 0
- Target Price
- TSVT $10.40
- JCE N/A
- AVG Volume (30 Days)
- TSVT 343.8K
- JCE 49.7K
- Earning Date
- TSVT 11-12-2024
- JCE 01-01-0001
- Dividend Yield
- TSVT N/A
- JCE 9.26%
- EPS Growth
- TSVT N/A
- JCE N/A
- EPS
- TSVT N/A
- JCE N/A
- Revenue
- TSVT $44,120,000.00
- JCE N/A
- Revenue This Year
- TSVT N/A
- JCE N/A
- Revenue Next Year
- TSVT $22.42
- JCE N/A
- P/E Ratio
- TSVT N/A
- JCE N/A
- Revenue Growth
- TSVT N/A
- JCE N/A
- 52 Week Low
- TSVT $1.54
- JCE $11.64
- 52 Week High
- TSVT $6.40
- JCE $14.28
- Technical
- Relative Strength Index (RSI)
- TSVT 49.73
- JCE 54.30
- Support Level
- TSVT $4.60
- JCE $15.04
- Resistance Level
- TSVT $4.92
- JCE $15.28
- Average True Range (ATR)
- TSVT 0.33
- JCE 0.17
- MACD
- TSVT -0.01
- JCE -0.01
- Stochastic Oscillator
- TSVT 46.57
- JCE 55.00
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest
Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities (the Options Strategy).